|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 22, 2017 ) Request sample copy of this report @ http://www.orbisresearch.com/contacts/request-sample/387946 .
Long–term Growth Projection:
Mammography grasp the dominant share in the United States Breast Cancer Screening Market
Breast MRI Screening market is likely to reach more than US$ 350 Million by 2022
Number of mammograpy screening population in United States will increase to
more than 50 Million by 2022
Market growth can be attributed to factors such as increasing incidence of breast cancer, increasing awareness related to early breast cancer detection, growing government investments and funding for breast cancer screening, technological advancement in breast imaging technologies and implementation of several initiatives to create awareness about the early detection of breast cancer.
United States Breast Cancer Screening Market Analysis: By Type, Share, Cases, Clinical Trials Insight, Reimbursement, Competitive Strategies and Forecast, 2017 - 2022” provides a deep and thorough evaluation of the United States Breast Cancer Screening Market. The report provides an in–depth analysis of the breast cancer invasive, in situ and men cases and added breast cancer death figures of both men and women in United States. Furthermore, the report also covered mammography screening population from 2010 to 2022.
Market outlook in value terms has been analyzed based on historical, current and potential trends and the market is projected from 2017 to 2022. The breast cancer screening market is segmented based on its product types: Mammography, Breast MRI and Breast Ultrasound. Additionally, the report includes assessment of clinical trials and reimbursement pattern. The report also explores detailed description of growth drivers and inhibitors of the United States Breast Cancer Screening Market.
The report concludes with the profiles of major manufacturers of Mammography, MRI and Ultrasound such as Hologic, Hitachi Medical Corporation, Siemen Healthineers, Philips Healthcare, Toshiba Medical Systems Corporation and GE Healthcare. The major manufacturers are evaluated on various parameters such as business overview, marketed products and latest development and trends
Browse Complete Report @ http://www.orbisresearch.com/reports/index/united-states-breast-cancer-screening-market-analysis-by-type-share-cases-clinical-trials-insight-reimbursement-competitive-strategies-and-forecast-2017-2022 .
Key Topics Covered in the Report
United States Breast Cancer Cases (2010 - 2022)
United States Breast Cancer Mammography Screening Population (2010 – 2022)
United States Breast Cancer Death (2010 – 2017)
Market Overview: United States Breast Cancer Screening (2010 – 2022)
Market Share: United States Breast Cancer Screening (2010 – 2022)
By Types (Mammography, Breast MRI & Breast Ultrasound): Market Size & Analysis (2010 – 2022)
Reimbursement Policies of the United States Breast Cancer Screening
Breast Cancer Screening Market Clinical Trail Insight by Phase, Company & Country
Key Drivers and Inhibitors of the United States Breast Cancer Screening Market
Key Manufacturers Analysis
Major Breast Cancer Screening Analyzed Under This Report Are:
Mamography
Breast Magnetic Resonance Imaging(MRI)
Breast Ultrasound
Major Companies Covered in This Report:
Hitachi Medical Corporation
Siemen Healthineers
Philips Healthcare
Toshiba Medical Systems Corporation
GE Healthcare
Hologic
Purchase a copy of Breast Cancer Screening Market visit @ http://www.orbisresearch.com/contact/purchase/387946 For more information contact sales@orbisresearch.com .
Some points from TOC:
Executive Summary
Breast Cancer Facts
United States Breast Cancer Cases & Population (2010 – 2022)
3.1 Breast Cancer Mammography Screening Population (2010 – 2022)
3.2 Breast Cancer Occurrence (2010–2022)
3.2.1 Total Breast Cancer Cases
3.2.1.1 Breast Cancer Invasive Cases
3.2.1.2 Breast Cancer In Situ Cases
3.2.1.3 Breast Cancer Men Cases
3.3 Breast Cancer Death (2010 – 2017)
3.3.1 Total Breast Cancer Death
3.3.1.1 Women Breast Cancer Death
3.3.1.2 Men Breast Cancer Death
Market Overview: United States Breast Cancer Screening (2010 – 2022)
Market Share: United States Breast Cancer Screening (2010 – 2022)
By Types: Market Size & Analysis (2010 – 2022)
6.1 Mammography Screening Market
6.2 Breast Magnetic Resonance Imaging (MRI) Screening Market
6.3 Breast Ultrasound Screening Market
Key Drivers and Inhibitors of the United States Breast Cancer Screening Market
7.1 Market Drivers
7.2 Market Inhibitors
Reimbursement Policies of the United States Breast Cancer Screening
8.1 Mammography
8.2 Breast Magnetic Resonance Imaging(MRI)
8.3 Breast Ultrasound
Breast Cancer Screening Market Clinical Trail Insight by Phase, Company & Country
9.1 Year 2017
9.2 Year 2016
9.3 Year 2015
Key Manufacturers Analysis
10.1 Hologic
10.1.1 Business Overview
10.1.2 Breast Cancer Screening – Marketed Products
10.1.2.1 Mammography
10.1.2.2 Magnetic Resonance Imaging(MRI)
10.1.3 Breast Cancer Screening – Latest Development & Trends
10.2 Hitachi Medical Corporation
10.2.1 Business Overview
10.2.2 Breast Cancer Screening – Marketed Products
10.2.2.1 Magnetic Resonance Imaging(MRI)
10.2.2.2 Ultrasound
10.2.3 Breast Cancer Screening – Latest Development & Trends
10.3 Siemens Healthineers
10.3.1 Business Overview
10.3.2 Breast Cancer Screening – Marketed Products
10.3.2.1 Mammography
10.3.2.2 Magnetic Resonance Imaging (MRI)
10.33 Breast Cancer Screening – Latest Development & Trends
10.4 Philips Healthcare
10.4.1 Business Overview
10.4.2 Breast Cancer Screening – Marketed Products
10.4.2.1 Mammography
10.4.2.2 Magnetic Resonance Imaging (MRI)
10.4.2.3 Ultrasound
10.4.3 Breast Cancer Screening – Latest Development & Trends
10.5 Toshiba Medical Systems Corporation
10.5.1 Business Overview
10.5.2 Breast Cancer Screening – Marketed Products
10.5.2.1 Mammography
10.5.2.2 Magnetic Resonance Imaging (MRI)
10.5.2.3 Ultrasound
10.5.3 Breast Cancer Screening – Latest Development & Trends
10.6 GE Healthcare
10.6.1 Business Overview
10.6.2 Breast Cancer Screening – Marketed Products
10.6.2.1 Mammography
10.6.2.2 Magnetic Resonance Imaging (MRI)
10.6.2.3 Ultrasound
10.6.3 Breast Cancer Screening – Latest Development & Trends
For any enquires before buying, connect with us @ enquiry@orbisresearch.com
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter: https://twitter.com/orbisresearch
Like us on Facebook: https://www.facebook.com/pages/Orbis-Research/820969017982115
Orbis Research
Hector Costello
+1 (214) 884-6817
sales@orbisresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
